Chaim Lebovits's Insider Trades & SAST Disclosures
Chaim Lebovits's most recent trade in Brainstorm Cell Therapeutics, Inc. was a trade of 120,000 Common Stock done . Disclosure was reported to the exchange on Jan. 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Chaim Lebovits.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 120,000 | 200,960 (0%) | 0% | 0 | Common Stock | |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.23 per share. | 30 Sep 2024 | 22,000 | 1,186,865 (4%) | 0% | 0.2 | 5,016 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 3.43 per share. | 30 Sep 2024 | 1,836 | 80,960 (0%) | 0% | 3.4 | 6,292 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.52 per share. | 28 May 2024 | 15,000 | 1,164,865 (4%) | 0% | 0.5 | 7,775 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 28 May 2024 | 15,000 | 1,164,865 (4%) | 0% | 0.5 | 7,775 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.58 per share. | 21 May 2024 | 25,000 | 1,124,865 (4%) | 0% | 0.6 | 14,475 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.64 per share. | 21 May 2024 | 25,000 | 1,149,865 (4%) | 0% | 0.6 | 16,000 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.58 per share. | 21 May 2024 | 25,000 | 1,124,865 (4%) | 0% | 0.6 | 14,475 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 21 May 2024 | 25,000 | 1,149,865 (4%) | 0% | 0.6 | 16,000 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.46 per share. | 10 May 2024 | 20,000 | 1,079,865 (4%) | 0% | 0.5 | 9,300 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.46 per share. | 10 May 2024 | 20,000 | 1,079,865 (4%) | 0% | 0.5 | 9,300 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.47 per share. | 10 May 2024 | 10,000 | 1,089,865 (4%) | 0% | 0.5 | 4,665 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.49 per share. | 10 May 2024 | 10,000 | 1,099,865 (4%) | 0% | 0.5 | 4,900 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.47 per share. | 10 May 2024 | 10,000 | 1,089,865 (4%) | 0% | 0.5 | 4,665 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.49 per share. | 10 May 2024 | 10,000 | 1,099,865 (4%) | 0% | 0.5 | 4,900 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.37 per share. | 07 May 2024 | 66,300 | 1,059,865 (4%) | 0% | 0.4 | 24,816 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.37 per share. | 07 May 2024 | 66,300 | 1,059,865 (4%) | 0% | 0.4 | 24,816 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.38 per share. | 06 May 2024 | 135,000 | 993,565 (3%) | 0% | 0.4 | 50,666 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.38 per share. | 06 May 2024 | 135,000 | 993,565 (3%) | 0% | 0.4 | 50,666 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.52 per share. | 19 Apr 2024 | 15,000 | 858,565 (3%) | 0% | 0.5 | 7,799 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 19 Apr 2024 | 15,000 | 858,565 (3%) | 0% | 0.5 | 7,799 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.55 per share. | 17 Apr 2024 | 130,000 | 728,493 (2%) | 0% | 0.5 | 70,941 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Apr 2024 | 130,000 | 728,493 (2%) | 0% | 0.5 | 70,941 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.53 per share. | 17 Apr 2024 | 115,072 | 843,565 (3%) | 0% | 0.5 | 60,470 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Purchase of securities on an exchange or from another person at price $ 0.53 per share. | 17 Apr 2024 | 115,072 | 843,565 (3%) | 0% | 0.5 | 60,470 | Common Stock |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 305,198 | 598,493 (2%) | 1% | 0 | Common Stock | |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2023 | 31,185 | 293,295 (1%) | 0% | 0 | Common Stock | |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | President & Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2023 | 75,000 | 262,110 (0%) | 0% | 0 | Common Stock | |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Sep 2022 | 31,185 | 187,110 (0%) | 0% | 0 | Common Stock | |
| Brainstorm Cell Therapeuti... | Chaim Lebovits | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2020 | 31,185 | 124,740 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges